Skip to main content

Table 1 Summary of commonly used guidelines in the management of head and neck squamous carcinoma cancer of unknown primary and their methodology

From: Methodology for the development of National Multidisciplinary Management Recommendations using a multi-stage meta-consensus initiative

Publishing/ endorsing organisation(s)

Organisation(s) abbreviation/ acronym

Year published/ updated

Publishing country

Journal

Title

Publication dedicated solely to HNSCCUP

Number of recommendations/

statements dedicated to HNSCCUP

Methodology

Patient/ public inclusion

United Kingdom National Multidisciplinary Guidelines for Head and Neck Cancerb

UK MDT

Anticipated 2022

UK

Journal of Laryngology and Otology

Management of head and neck squamous cell carcinoma of unknown primary (HNSCCUP): United Kingdom National Multidisciplinary Guidelines

Yes

28

A National Consensus Day including 227 multidisciplinary attendees generated draft statements based on systematic reviews and expert presentations.

A priori methodology published.

Consultation included a National Delphi Exercise to gauge consensus for inclusion of recommendation.

Peer reviewed.

Patient experience presentation delivered at National Consensus Day prior to generation of draft consensus statements.

British Association of Head and Neck Oncologists standards

BAHNO

2021

UK

Journal of Oral Pathology and Medicine

British Association of Head and Neck Oncologists (BAHNO) standards 2020

No

5

20 multidisciplinary authors took reference from national published guidance to inform the recommendations.

No a priori methodology published.

No wider consultation following development was declared.

Peer reviewed.

Nil

National Comprehensive Cancer Network

NCCN

2021

USA

Head and Neck Cancer Guidelines (Version 1.2022)

No

4 flowchart and roughly 9 statements

Developed by a multidisciplinary panel of 36 experts and 2 support staff.

A priori methodology published.

No wider consultation following development was declared.

No Peer review prior to publication.

Inclusion of a patient advocate on the panel is encouraged but their involvement is not explicitly declared.

American Society of Clinical Oncology

ASCO

2020

USA

Journal of Clinical Oncology

Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline

Yes

33

15 multidisciplinary authors formed an Expert Panel who assessed 100 relevant articles from systematic reviews.

A priori methodology published.

Consultation included an open public comment period of two weeks.

Peer reviewed.

Draft recommendations were open to public comment on signing a confidentiality agreement.

European Head and Neck Society, European Society for Medical Oncology, and European SocieTy for Radiotherapy and Oncology

EHNS/ESMO/ESTRO

2020

Europe

Annals of Oncology

Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

No

Roughly 250 words of prose

20 multidisciplinary authors assessed evidence and wrote guidelines.

A priori methodology published.

No wider consultation following development declared.

Peer reviewed.

Nil

National Institute for Health and Care Excellence

NICE

2018

UK

Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over

No

8

A multidisciplinary advisory group forms a writing committee to generate draft statements based on ‘evidence reviews’.

A priori methodology published.

Consultation included release of draft guidelines for input from registered stakeholders.

Peer reviewed ‘may occasionally be considered’ but not explicitly declared.

Included in the guideline generating committee.

United Kingdom National Multidisciplinary Guidelines for Head and Neck Cancera

UK MDT

2016

UK

Journal of Laryngology and Otology

Investigation and management of the unknown primary with metastatic neck disease: United Kingdom National Multidisciplinary Guidelines

Yes

10

Five multidisciplinary experts HNC.

No a priori methodology published.

No wider consultation following development was declared.

Peer reviewed.

Nil

  1. aguidelines endorsed: by the British Association of Otorhinolaryngology-Head & Neck Surgery (ENT UK); the British Association of Oral and Maxillofacial Surgeons (BAOMS); the British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS); British Association of Head and Neck Oncologists (BAHNO); The Royal College of Pathologists (RCPath); The Royal College of Radiologists (RCR); and the British Association of Endocrine and Thyroid Surgeons (BAETS)
  2. bendorsing organisations to be confirmed prior to publication